Canaccord Genuity Maintains Hold on Bioceres Crop Solutions, Lowers Price Target to $2

Benzinga · 5d ago
Canaccord Genuity analyst Austin Moeller maintains Bioceres Crop Solutions (NASDAQ:BIOX) with a Hold and lowers the price target from $2.25 to $2.